SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-027804
Filing Date
2022-10-06
Accepted
2022-10-06 16:05:19
Documents
14
Period of Report
2022-09-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34341
2 ex3-1.htm EX-3.1 1096
3 ex3-1_001.jpg GRAPHIC 300662
  Complete submission text file 0001493152-22-027804.txt   616896

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atrx-20220930.xsd EX-101.SCH 3236
5 XBRL LABEL FILE atrx-20220930_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE atrx-20220930_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3287
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 221298208
SIC: 2834 Pharmaceutical Preparations